AIBullishCrypto Briefing · 5h ago7/10
🧠
Nvidia and Genentech make the case for AI-driven drug discovery at BIO2026
Nvidia and Genentech presented at BIO2026 on how artificial intelligence is transforming drug discovery by accelerating research timelines, reducing development costs, and enabling personalized treatment approaches. This collaboration highlights the growing convergence of AI technology and pharmaceutical innovation as a major driver of healthcare advancement.
🏢 Nvidia